XML 17 R11.htm IDEA: XBRL DOCUMENT

Accrued Interest Receivable	3 Months Ended
Oct. 31, 2019
Notes to Financial Statements
Accrued Interest Receivable	NOTE 5. ACCRUED INTEREST RECEIVABLE Accrued Interest Receivable recognized in the reverse merger consists of $6,884 of interest earned but not received due to the Company by Regen Biopharma, Inc. and recognized in the reverse merger. Accrued Interest Receivable of $6,884 is due at the demand of the Company.

Accrued Interest Receivable

3 Months Ended

Oct. 31, 2019

NOTE 5. ACCRUED INTEREST RECEIVABLE

Accrued Interest Receivable recognized in the reverse merger consists of $6,884 of interest earned but not received due to the Company by Regen Biopharma, Inc. and recognized in the reverse merger. Accrued Interest Receivable of $6,884 is due at the demand of the Company.